{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:37:20Z","timestamp":1793525840081,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107916","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:25:38Z","timestamp":1729815938000},"page":"107916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer\u2019s disease and type-2 diabetes mellitus"],"prefix":"10.1016","volume":"153","author":[{"given":"Yusuke","family":"Hatakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-0815","authenticated-orcid":false,"given":"Tomoyuki","family":"Oe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107916_b0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0083-6729(08)00622-5","article-title":"Structure, function, and regulation of insulin-degrading enzyme","volume":"80","author":"Hulse","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bioorg.2024.107916_b0010","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","article-title":"Insulin-degrading enzyme in the fight against Alzheimer's disease","volume":"39","author":"Kurochkin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.107916_b0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","article-title":"Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?","volume":"48","author":"Pivovarova","year":"2016","journal-title":"Ann. Med."},{"key":"10.1016\/j.bioorg.2024.107916_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0315-7","article-title":"Differential effects of diet-and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Wakabayashi","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bioorg.2024.107916_b0030","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","article-title":"Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies","volume":"4","author":"Gudala","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.bioorg.2024.107916_b0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2024.107916_b0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer's disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107916_b0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioorg.2024.107916_b0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: An emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2024.107916_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.bioorg.2024.107916_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the \u03b2-Amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2024.107916_b0065","article-title":"Comparative studies for amyloid beta degradation: \u201cNeprilysin vs insulysin\u201d, \u201cmonomeric vs aggregate\u201d, and \u201cwhole A\u03b240 vs its peptide fragments\u201d","volume":"30","author":"Kato","year":"2022","journal-title":"B. b. Reports"},{"key":"10.1016\/j.bioorg.2024.107916_b0070","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2024.107916_b0075","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2024.107916_b0080","doi-asserted-by":"crossref","first-page":"e20818","DOI":"10.1371\/journal.pone.0020818","article-title":"Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance","volume":"6","author":"Abdul-Hay","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bioorg.2024.107916_b0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2024.107916_b0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13297","article-title":"Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones","volume":"511","author":"Maianti","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107916_b0095","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/jm301280p","article-title":"Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity","volume":"56","author":"Abdul-Hay","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0100","doi-asserted-by":"crossref","first-page":"20044","DOI":"10.1074\/jbc.M115.638205","article-title":"Dual exosite-binding inhibitors of insulin-degrading enzyme challenge its role as the primary mediator of insulin clearance in vivo","volume":"290","author":"Durham","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0105","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1038\/ncomms9250","article-title":"Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice","volume":"6","author":"Deprez-Poulain","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.107916_b0110","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1021\/acs.jmedchem.8b00418","article-title":"Stabilized \u03b2-hairpin peptide inhibits insulin degrading enzyme","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0115","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acschembio.5b00334","article-title":"Selective targeting of extracellular insulin-degrading enzyme by quasi-irreversible thiol-modifying inhibitors","volume":"10","author":"Abdul-Hay","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107916_b0120","doi-asserted-by":"crossref","first-page":"e0193101","DOI":"10.1371\/journal.pone.0193101","article-title":"Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display","volume":"13","author":"Suire","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bioorg.2024.107916_b0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41589-019-0271-0","article-title":"Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme","volume":"15","author":"Maianti","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107916_b0130","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cmdc.202100111","article-title":"Hydroxypyridinethione inhibitors of human insulin-degrading enzyme","volume":"16","author":"Adamek","year":"2021","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/10409238.2017.1337707","article-title":"Multiple functions of insulin-degrading enzyme: a metabolic crosslight?","volume":"52","author":"Tundo","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107916_b0140","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443","author":"Shen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107916_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(94)01079-X","article-title":"Families of zinc metalloproteases","volume":"354","author":"Hooper","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2024.107916_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tem.2015.11.003","article-title":"Targeting insulin-degrading enzyme to treat type 2 diabetes mellitus","volume":"27","author":"Tang","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2024.107916_b0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/acs.biochem.6b00783","article-title":"Toward allosterically increased catalytic activity of insulin-degrading enzyme against amyloid peptides","volume":"56","author":"Kurochkin","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107916_b0160","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/biom13101492","article-title":"The insulin-degrading enzyme from structure to allosteric modulation: New perspectives for drug design","volume":"13","author":"Tundo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2024.107916_b0165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11095-022-03237-7","article-title":"Inhibition of insulin degrading enzyme to control diabetes mellitus and its applications on some other chronic disease: A critical review","volume":"39","author":"Azam","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2024.107916_b0170","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.2174\/138161209789271799","article-title":"Insulin-degrading enzyme: Structure-function relationship and its possible roles in health and disease","volume":"15","author":"Fernandez-Gamba","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2024.107916_b0175","doi-asserted-by":"crossref","first-page":"17701","DOI":"10.1074\/jbc.M501896200","article-title":"Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions","volume":"280","author":"Song","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0180","doi-asserted-by":"crossref","first-page":"21538","DOI":"10.1016\/S0021-9258(20)80575-4","article-title":"Functional analysis of conserved residues in the active site of insulin-degrading enzyme","volume":"268","author":"Perlman","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0185","doi-asserted-by":"crossref","first-page":"14804","DOI":"10.1021\/ja9037142","article-title":"Human insulin-degrading enzyme working mechanism","volume":"131","author":"Amata","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107916_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166993","article-title":"Degradation of Alzheimer\u2019s amyloid-\u03b2 by a catalytically inactive insulin-degrading enzyme","volume":"433","author":"Sahoo","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2024.107916_b0195","doi-asserted-by":"crossref","first-page":"e31787","DOI":"10.1371\/journal.pone.0031787","article-title":"Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme","volume":"7","author":"Cakir","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bioorg.2024.107916_b0200","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1021\/acs.biochem.8b00474","article-title":"Molecular determinants of substrate specificity in human insulin-degrading enzyme","volume":"57","author":"Stefanidis","year":"2018","journal-title":"Biochem."},{"key":"10.1016\/j.bioorg.2024.107916_b0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0040-4039(00)70917-8","article-title":"4-Phenyl-1,2,4-triazolin-3,5-dione: a powerful dienophile","volume":"14","author":"Cookson","year":"1962","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2024.107916_b0210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/bc300665t","article-title":"Facile and stabile linkages through tyrosine: bioconjugation strategies with the tyrosine-click reaction","volume":"24","author":"Ban","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.bioorg.2024.107916_b0215","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/pro.3897","article-title":"Discriminating changes in protein structure using tyrosine conjugation","volume":"29","author":"Moinpour","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2024.107916_b0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.apradiso.2015.06.021","article-title":"Improved synthesis of [18F]FS-PTAD as a new tyrosine-specific prosthetic group for radiofluorination of biomolecules","volume":"104","author":"Al-Momani","year":"2015","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.bioorg.2024.107916_b0225","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1021\/acschembio.5b00440","article-title":"Tyrosine-specific chemical modification with in situ hemin-activated luminol derivatives","volume":"10","author":"Sato","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107916_b0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1248\/cpb.c21-00915","article-title":"Protein chemical modification using highly reactive species and spatial control of catalytic reactions","volume":"70","author":"Sato","year":"2022","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2024.107916_b0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijms.2009.02.008","article-title":"MALDI, AP\/MALDI and ESI techniques for the MS detection of amyloid \u03b2-peptides Int","volume":"282","author":"Grasso","year":"2009","journal-title":"J. Mass Spectom."},{"key":"10.1016\/j.bioorg.2024.107916_b0240","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbagen.2016.03.010","article-title":"Characterization of insulin-degrading enzyme-mediated cleavage of A\u03b2 in distinct aggregation states","volume":"1860","author":"Hubin","year":"2016","journal-title":"Bichim. Biophys. Acta"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:27:02Z","timestamp":1738204022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0045206824008216"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107916","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer\u2019s disease and type-2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107916"}}